Correlation Between Mink Therapeutics and COMCAST
Specify exactly 2 symbols:
By analyzing existing cross correlation between Mink Therapeutics and COMCAST P NEW, you can compare the effects of market volatilities on Mink Therapeutics and COMCAST and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mink Therapeutics with a short position of COMCAST. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mink Therapeutics and COMCAST.
Diversification Opportunities for Mink Therapeutics and COMCAST
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Mink and COMCAST is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Mink Therapeutics and COMCAST P NEW in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on COMCAST P NEW and Mink Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mink Therapeutics are associated (or correlated) with COMCAST. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of COMCAST P NEW has no effect on the direction of Mink Therapeutics i.e., Mink Therapeutics and COMCAST go up and down completely randomly.
Pair Corralation between Mink Therapeutics and COMCAST
Given the investment horizon of 90 days Mink Therapeutics is expected to generate 30.86 times more return on investment than COMCAST. However, Mink Therapeutics is 30.86 times more volatile than COMCAST P NEW. It trades about 0.1 of its potential returns per unit of risk. COMCAST P NEW is currently generating about -0.17 per unit of risk. If you would invest 884.00 in Mink Therapeutics on November 28, 2024 and sell it today you would earn a total of 82.00 from holding Mink Therapeutics or generate 9.28% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Mink Therapeutics vs. COMCAST P NEW
Performance |
| Timeline |
| Mink Therapeutics |
| COMCAST P NEW |
Mink Therapeutics and COMCAST Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mink Therapeutics and COMCAST
The main advantage of trading using opposite Mink Therapeutics and COMCAST positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mink Therapeutics position performs unexpectedly, COMCAST can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in COMCAST will offset losses from the drop in COMCAST's long position.| Mink Therapeutics vs. Affimed NV | Mink Therapeutics vs. Adaptimmune Therapeutics Plc | Mink Therapeutics vs. Sangamo Therapeutics | Mink Therapeutics vs. Day One Biopharmaceuticals |
| COMCAST vs. Universal Display | COMCAST vs. Sonos Inc | COMCAST vs. Canlan Ice Sports | COMCAST vs. First Ship Lease |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |